chr15-42394296-G-A
Variant summary
Our verdict is Likely pathogenic. The variant received 9 ACMG points: 9P and 0B. PM1PM5PP3_StrongPP5
The NM_000070.3(CAPN3):c.1070G>A(p.Arg357Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000425 in 1,410,970 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R357W) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000070.3 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive limb-girdle muscular dystrophyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- autosomal recessive limb-girdle muscular dystrophy type 2AInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Myriad Women’s Health, Labcorp Genetics (formerly Invitae)
- muscular dystrophy, limb-girdle, autosomal dominant 4Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- muscular dystrophy, limb-girdle, autosomal dominantInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 9 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CAPN3 | NM_000070.3 | c.1070G>A | p.Arg357Gln | missense_variant | Exon 8 of 24 | ENST00000397163.8 | NP_000061.1 | |
| CAPN3 | NM_024344.2 | c.1070G>A | p.Arg357Gln | missense_variant | Exon 8 of 23 | NP_077320.1 | ||
| CAPN3 | NM_173087.2 | c.926G>A | p.Arg309Gln | missense_variant | Exon 7 of 21 | NP_775110.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CAPN3 | ENST00000397163.8 | c.1070G>A | p.Arg357Gln | missense_variant | Exon 8 of 24 | 1 | NM_000070.3 | ENSP00000380349.3 | ||
| ENSG00000258461 | ENST00000495723.1 | n.*866G>A | non_coding_transcript_exon_variant | Exon 12 of 26 | 2 | ENSP00000492063.1 | ||||
| ENSG00000258461 | ENST00000495723.1 | n.*866G>A | 3_prime_UTR_variant | Exon 12 of 26 | 2 | ENSP00000492063.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000578 AC: 1AN: 173076 AF XY: 0.0000109 show subpopulations
GnomAD4 exome AF: 0.00000425 AC: 6AN: 1410970Hom.: 0 Cov.: 31 AF XY: 0.00000430 AC XY: 3AN XY: 697068 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Autosomal recessive limb-girdle muscular dystrophy type 2A Uncertain:3
- -
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 357 of the CAPN3 protein (p.Arg357Gln). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individuals with autosomal recessive limb-girdle muscular dystrophy (PMID: 15733273, 32528171, 33337384). ClinVar contains an entry for this variant (Variation ID: 430022). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CAPN3 protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
not provided Pathogenic:1Uncertain:1
Reported previously in a cohort of patients with unexplained limb-girdle weakness; however, it was unclear if a second variant was found (PMID: 32528171); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 15733273, 17702496, 32528171, 33337384) -
- -
Autosomal recessive limb-girdle muscular dystrophy Pathogenic:1
Variant summary: CAPN3 c.1070G>A (p.Arg357Gln) results in a conservative amino acid change located in the Peptidase C2, calpain, catalytic domain of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 5.8e-06 in 173076 control chromosomes. c.1070G>A has been reported in the literature in individuals affected with Limb-Girdle Muscular Dystrophy, including one patient in the homozygous state, and in a patient with unexplained limb-girdle weakness and/or elevated CK (Hanisch_2007, Todorova_2005, Topf_2020, Pathak_2021). The variant was reported in a patient with absent Calpain 3 on Western blot, who also carried a truncating CAPN3 variant (Todorova_2005). Four clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Three submitters classified the variant as VUS while one classified as likely pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Autosomal recessive limb-girdle muscular dystrophy type 2A;C4748295:Muscular dystrophy, limb-girdle, autosomal dominant 4 Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at